|
시장보고서
상품코드
2024422
구조적 심장 영상 진단 시장 보고서 : 영상 진단법, 검사 유형, 용도, 최종사용자, 지역별(2026-2034년)Structural Heart Imaging Market Report by Imaging Modality, Procedure Type, Application, End User, and Region 2026-2034 |
||||||
세계의 구조적 심장 이미징 시장 규모는 2025년에 234억 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 480억 달러에 달하며, 2026-2034년에 CAGR 8.05%로 성장할 것으로 예측하고 있습니다.
구조적 심장 이미징(SHI)은 분자 수준에서 심장의 스크리닝 및 검사를 위해 의료 산업에서 널리 도입되고 있는 특수 기술입니다. 이 방법은 빛의 반사를 이용하여 내부 구조의 이미지를 생성하고 2D 단면 분석을 통해 명확하고 정확한 진단을 가능하게 합니다. 또한 폐색 부위 확인, 카테터 삽입 경로 확인 등 다양한 수술시 의료진을 도와 간섭의 위험을 최소화하는 역할도 하고 있습니다.
구조적 심장 영상 시장 동향:
선천성 심장질환과 과도한 알코올 섭취 및 건강에 해로운 식습관으로 인한 비만, 당뇨병, 고혈압과 같은 생활습관병의 유병률 증가는 세계의 심장 영상 시장의 성장을 이끄는 주요 요인 중 하나입니다. 또한 소비자들의 건강에 대한 인식이 높아진 것도 전 세계 시장에 긍정적인 영향을 미치고 있습니다. 여기에 더해 고정밀, 고해상도 카메라 및 센서의 지원으로 비판막성 및 판막성 심장질환 등 다양한 심장질환에 대처하기 위한 SHI(구조적 심장영상)의 보급이 시장 성장에 크게 기여하고 있습니다. 또한 수술 후 환자의 즉각적인 회복을 보장하여 심장질환을 중재적으로 치료하는 경피적 대동맥판막 치환술(TAVR)의 도입이 시장 성장을 촉진하고 있습니다. 이 외에도 첨단 구조적 심장 영상 및 심장 시스템 도입을 위한 연구개발 활동에 대한 투자 증가는 시장 전망을 밝게 하고 있습니다. 이에 따라 각국 정부가 환자의 건강을 보장하기 위해 의료 인프라를 개선하기 위해 시행하고 있는 다양한 노력도 시장을 더욱 견인하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 구조적 심장 영상 진단 시장
제6장 시장 내역 : 영상 진단법별
제7장 시장 내역 : 시술 유형별
제8장 시장 내역 : 용도별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porters Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KSA 26.05.14The global structural heart imaging market size reached USD 23.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 48.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.05% during 2026-2034.
Structural heart imaging (SHI) is a special technique, which is extensively deployed in the healthcare industry for screening and examining the heart at the molecular level. This procedure includes the utilization of light reflection for producing the interior element images and creating a 2-dimensional cross-section analysis to get a clarified and accurate diagnosis. It is further used for enabling and assisting professionals while performing various operative procedures, such as locating the blockages and pathways for insertion by minimizing the risk of interference.
STRUCTURAL HEART IMAGING MARKET TRENDS:
The escalating prevalence of various congenital, cardiac diseases and lifestyle-induced ailments, such as obesity, diabetes, and high blood pressure due to excessive alcohol consumption and unhealthy eating habits, is one of the primary factors majorly driving the global heart imaging market toward the growth. Furthermore, the rising health consciousness amongst the consumers is positively influencing the market across the globe. In addition to this, the widespread adoption of SHI for addressing various heart conditions, such as non-valvular and valvular heart diseases, with the support of high precision and resolution cameras and sensors is considerably contributing to the market growth. Moreover, the introduction of transcatheter aortic valve replacement (TAVR) for operating heart diseases interventions by ensuring instant recovery of consumers post-surgery is promoting the growth of the market. Other than this, the rising investments in research and development (R&D) activities for introducing advanced structural heart imaging and cardiac systems is creating a positive outlook for the market. In line with this, the market is further being driven by the numerous initiatives undertaken by the governments of various nations for improving the healthcare infrastructure to ensure patients wellness.
KEY MARKET SEGMENTATION:
Breakup by Imaging Modality:
- Echocardiogram
- Angiogram
- CT
- MRI
Breakup by Procedure Type:
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Transcatheter Mitral Valve Repair (TMVR)
- Left Atrial Appendage Closure (LAAC)
- Annuloplasty
- Valvuloplasty
- Others
Breakup by Application:
- Diagnosis
- Surgery
Breakup by End User:
- Hospitals
- Specialty Clinics
- Cardiac Centers
- Diagnostic Centers
- Ambulatory Surgical Centers
- Catheterization Laboratories
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report provides a comprehensive analysis of the competitive landscape in the global structural heart imaging market with detailed profiles of all major companies, including:
- Abbott Laboratories
- Boston Scientific Corporation
- Canon Medical Systems Corporation
- Circle Cardiovascular Imaging Inc.
- Esaote SPA
- FUJIFILM Holdings Corporation
- Koninklijke Philips N.V
- Mindray Medical India Pvt. Ltd
- Samsung Healthcare
- Shimadzu Corporation
- Siemens Healthineers
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Structural Heart Imaging Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Imaging Modality
- 6.1 Echocardiogram
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Angiogram
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 CT
- 6.2.2.2 MRI
- 6.2.3 Market Forecast
7 Market Breakup by Procedure Type
- 7.1 Transcatheter Aortic Valve Replacement (TAVR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Surgical Aortic Valve Replacement (SAVR)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Transcatheter Mitral Valve Repair (TMVR)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Left Atrial Appendage Closure (LAAC)
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Annuloplasty
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Valvuloplasty
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by Application
- 8.1 Diagnosis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Surgery
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Specialty Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Cardiac Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Diagnostic Centers
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Ambulatory Surgical Centers
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
- 9.6 Catheterization Laboratories
- 9.6.1 Market Trends
- 9.6.2 Market Forecast
- 9.7 Others
- 9.7.1 Market Trends
- 9.7.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Boston Scientific Corporation
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Canon Medical Systems Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Circle Cardiovascular Imaging Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Esaote SPA
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 FUJIFILM Holdings Corporation
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Koninklijke Philips N.V
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Mindray Medical India Pvt. Ltd
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Samsung Healthcare
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Shimadzu Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Siemens Healthineers
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
